Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study aimed to follow the natural progression of retinal changes in patients with diabetes. Such information should inform decisions with regard to the screening intervals for such patients. RESEARCH DESIGN AND METHODS: An observational study was undertaken linking the data from seven diabetes retinal screening programs across the U.K. for retinal grading results between 2005 and 2012. Patients with absent or background retinopathy were followed up for progression to the end points referable retinopathy and treatable retinopathy (proliferative retinopathy). RESULTS: In total, 354,549 patients were observed for up to 4 years during which 16,196 patients progressed to referable retinopathy. Of patients with no retinopathy in either eye for two successive screening episodes at least 12 months apart, the conditions of between 0.3% (95% CI 0.3–0.8%) and 1.3% (1.0–1.6%) of patients progressed to referable retinopathy, and rates of treatable eye disease were <0.3% at 2 years. The corresponding progression rates for patients with bilateral background retinopathy in successive screening episodes were 13–29% and up to 4%, respectively, in the different programs. CONCLUSIONS: It may be possible to stratify patients for risk, according to baseline retinal criteria, into groups with low and high risk of their conditions progressing to proliferative retinopathy. Screening intervals for such diverse groups of patients could safely be modified according to their risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Artificial intelligence approaches to screening for diabetic retinopathy have progressed to the point of utility and cost-effectiveness.508–513”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [512]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030398010 · Cited by 1,885
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030405011 · Cited by 1,477
Elman, M. J., Aiello, L. P., Beck, R. W., Bressler, N. M., Bressler, S. B., Edwards, A. R., Ferris, F. L., Friedman, S. M., Glassman, A. R., Miller, K. M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.031 · Cited by 1,428
Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,326
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1987) · Ophthalmology · doi:10.1016/s0161-6420(87)33525-0 · Cited by 1,249
Photocoagulation Treatment of Proliferative Diabetic Retinopathy
(1981) · Ophthalmology · doi:10.1016/s0161-6420(81)34978-1 · Cited by 975
Photocoagulation for Diabetic Macular Edema
Aiello, L. M., & Ferris, F. L. (1987) · Archives of Ophthalmology · doi:10.1001/archopht.1987.01060090021004 · Cited by 733
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
Massin, P., Bandello, F., Garweg, J. G., Hansen, L. L., Harding, S. P., Larsen, M., Mitchell, P., Sharp, D., Wolf-Schnurrbusch, U. E. K., Gekkieva, M., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0493 · Cited by 720
Younis, N., Broadbent, D. M., Vora, J. P., & Harding, S. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12267-2 · Cited by 289
Research works printed but not linked: 1
- Leese, 2005, Implementation of national diabetes retinal screening programme is associated with a reduced referral rate to ophthalmology, 1112
Cited by
Screening for diabetic retinopathy: new perspectives and challenges
Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, P., Peto, T., & Simó, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30411-5 · Cited by 671
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters
Hartmann-Boyce, J., Morris, E., Goyder, C., Kinton, J., Perring, J., Nunan, D., Mahtani, K., Buse, J. B., Del Prato, S., Ji, L., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1192 · Cited by 251
S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression
(2017) · Springer eBooks · doi:10.1007/978-3-662-52906-5 · Cited by 210
Sim, D. A., Mitry, D., Alexander, P., Mapani, A., Goverdhan, S., Aslam, T., Tufail, A., Egan, C. A., & Keane, P. A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816629983 · Cited by 79
Robb, K. A. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101427 · Cited by 70
Screening Intervals for Diabetic Retinopathy and Implications for Care
Scanlon, P. H. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0928-6 · Cited by 59
Self-citationScreening attendance, age group and diabetic retinopathy level at first screen
Scanlon, P. H., Stratton, I. M., Leese, G. P., Bachmann, M. O., Land, M., Jones, C., Ferguson, B., & the Four Nations Diabetic Retinopathy Screening Study Group (2016) · Diabetic Medicine · doi:10.1111/dme.12957 · Cited by 56
Self-citationthe ISDR Study Group, Broadbent, D., Wang, A., Cheyne, C. P., James, M., Lathe, J., STRATTON, I. M., Roberts, J., Moitt, T., Vora, J. P., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05313-2 · Cited by 52
Self-citationThe prevention and treatment of retinal complications in diabetes
Schorr, S. G., Hammes, H., Müller, U. A., Abholz, H., Landgraf, R., & Bertram, B. (2016) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2016.0816 · Cited by 51
Ziemssen, F., Lemmen, K. D., Bertram, B., Hammes, H., & Agostini, H. T. (2016) · Der Ophthalmologe · doi:10.1007/s00347-016-0315-8 · Cited by 50
Bek, T. (2020) · Diabetologia · doi:10.1007/s00125-020-05234-0 · Cited by 42
for the Individualised Screening for Diabetic Retinopathy (ISDR) Study Group, Eleuteri, A., Fisher, A. C., Broadbent, D. M., García-Fiñana, M., Cheyne, C. P., Wang, A., Stratton, I. M., Gabbay, M., Seddon, D., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4386-0 · Cited by 39
Self-citationStrutton, R., Du Chemin, A., Stratton, I. M., & Forster, A. S. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010952 · Cited by 38
Self-citationRisk of diabetic retinopathy at first screen in children at 12 and 13 years of age
Scanlon, P. H., STRATTON, I. M., Bachmann, M. O., Jones, C., Leese, G., & the Four Nations Diabetic Retinopathy Screening Study Group (2016) · Diabetic Medicine · doi:10.1111/dme.13263 · Cited by 35
Self-citationAzeze, T. K., Sisay, M. M., & Zeleke, E. G. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3660-7 · Cited by 34
Diabetic retinopathy screening and treatment through the Brazilian National Health Insurance
Fernandes, A. G., Ferraz, A. N., Brant, R., & Malerbi, F. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-18054-6 · Cited by 33
McGurnaghan, S. J., Blackbourn, L. A. K., Caparrotta, T. M., Mellor, J., Barnett, A. L., Collier, A., Sattar, N. A., McKnight, J. A., Petrie, J. R., Philip, S., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-063046 · Cited by 32
Self-citationScotland, G., & Bryan, S. (2016) · Medical Decision Making · doi:10.1177/0272989x16653397 · Cited by 28
Broadbent, D., Sampson, C., Wang, A., Howard, L., Williams, A. E., Howlin, S. U., Appelbe, D. E., Moitt, T., Cheyne, C. P., Mobayen‐Rahni, M., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025788 · Cited by 27
Self-citationFaes, L., Fu, D. J., Huemer, J. C., Kern, C., Wagner, S. K., Fasolo, S., HAMILTON, R. D., Egan, C. A., Balaskas, K., Keane, P. A., et al. (2020) · Eye · doi:10.1038/s41433-020-01240-z · Cited by 21
Chen, L., Zhang, X., & Wen, F. (2018) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-018-3971-3 · Cited by 19
Thomas, R., Winfield, T. G., Prettyjohns, M., Dunstan, F., Cheung, W., Anderson, P. M., Peter, R., Luzio, S. D., & Owens, D. R. (2020) · The European Journal of Health Economics · doi:10.1007/s10198-020-01191-y · Cited by 18
Scotland, G., McKeigue, P., Philip, S., Leese, G., Olson, J. A., Looker, H. C., Colhoun, H. M., & Javanbakht, M. (2016) · Diabetic Medicine · doi:10.1111/dme.13129 · Cited by 18
Self-citationNderitu, P., Nunez do Rio, J. M., Webster, L., Mann, S., Cardoso, M. J., Modat, M., Hopkins, D., Bergeles, C., & Jackson, T. L. (2024) · Communications Medicine · doi:10.1038/s43856-024-00590-z · Cited by 16
Evidence Based Prediction and Progression Monitoring on Retinal Images from Three Nations
turk, L. I. A., Wang, S., Krause, P., Wawrzynski, J. R., Saleh, G. M., Alsawadi, H., Alshamrani, A. Z., Pető, T., Bastawrous, A., Li, J., et al. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.2.44 · Cited by 16
Complementary Approaches to Retinal Health Focusing on Diabetic Retinopathy
Rák, T., Kovács-Valasek, A., Pöstyéni, E., Csutak, A., & Gabriel, R. (2023) · Cells · doi:10.3390/cells12232699 · Cited by 13
Heggie, R., Chappell, F. M., Crawford, F., Martin, A., Gupta, S., Hawkins, N., Horne, M., Leese, G., & Lewsey, J. (2020) · Diabetic Medicine · doi:10.1111/dme.14339 · Cited by 13
Self-citationOlvera‐Barrios, A., Rudnicka, A. R., Anderson, J., Bolter, L., Chambers, R., Warwick, A., Welikala, R. A., Fajtl, J., Barman, S. A., Remgnino, P., et al. (2023) · British Journal of Ophthalmology · doi:10.1136/bjo-2023-324097 · Cited by 11
Byrne, P., Thetford, C., Gabbay, M., Clarke, P. M., Doncaster, E., Harding, S. P., for the ISDR Study Group, Harding, S. P., Broadbent, D., Byrne, P., et al. (2020) · BMC Public Health · doi:10.1186/s12889-020-08974-1 · Cited by 9
Self-citationA systematic review of diabetic retinopathy screening intervals
Drinkwater, J. J., Kalantary, A., & Turner, A. W. (2023) · Acta Ophthalmologica · doi:10.1111/aos.15788 · Cited by 9
Thomas, R., & Ng, S. M. (2020) · Journal of Diabetes and Clinical Research · doi:10.33696/diabetes.1.021 · Cited by 8
Using Data to Improve the Management of Diabetes: The Tayside Experience
Siddiqui, M. K., Hall, C., Cunningham, S. G., McCrimmon, R. J., Morris, A. D., Leese, G., & Pearson, E. R. (2022) · Diabetes Care · doi:10.2337/dci22-0003 · Cited by 7
Self-citationRutter, M. K., Carr, M., Wright, A. K., Kanumilli, N., Milne, N., Jones, E., Elton, P., Ceriello, A., Misra, A., Prato, S. D., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111693 · Cited by 7
Hughes, D., Nair, S., & Harvey, J. N. (2016) · Journal of Medical Screening · doi:10.1177/0969141316672687 · Cited by 7
Management of Diabetes Mellitus
Jenkins, A. J., SCOTT, E. S., Fulcher, J., Kilov, G., & Januszewski, A. S. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_7 · Cited by 6
Harding, S. P., Alshukri, A., Appelbe, D., Broadbent, D., Burgess, P. I., Byrne, P., Cheyne, C. P., Eleuteri, A., Fisher, A., García‐Fiñana, M., et al. (2023) · Programme Grants for Applied Research · doi:10.3310/hrfa3155 · Cited by 6
Self-citationCuadros, J. A. (2015) · Smart Homecare Technology and TeleHealth · doi:10.2147/shtt.s64448 · Cited by 6
Mellor, J., Jiang, W., Fleming, A., McGurnaghan, S. J., Blackbourn, L. A. K., Styles, C., Storkey, A., McKeigue, P., & Colhoun, H. M. (2024) · British Journal of Ophthalmology · doi:10.1136/bjo-2023-323400 · Cited by 6
Ziemssen, F., Marahrens, L., & Roeck, D. (2015) · Diabetes Care · doi:10.2337/dc15-1356 · Cited by 5
Aravindhan, A., Fenwick, E., Chan, A. W. D., Man, R. E. K., Tan, N. C., Wong, W. T., Soo, W. F., Lim, S. W., Wee, S. Y.-M., Sabanayagam, C., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-18287-2 · Cited by 4
Self-citationStratifying the NHS Diabetic Eye Screening Programme: into the unknown?
Sampson, C., James, M., Broadbent, D., & Harding, S. P. (2016) · Diabetic Medicine · doi:10.1111/dme.13192 · Cited by 4
Cribado de patología oftalmológica
Bravo, L. J. N., & García, R. A. A. (2019) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2018.10.011 · Cited by 2
Brodie, J., Misra, A., Jones, C. D., Jenkins, C. A., & Bachmann, M. O. (2023) · Diabetic Medicine · doi:10.1111/dme.15164 · Cited by 2
Self-citationCoelho-Costa, I., Silva-Pereira, A., Mota-Moreira, P., Marques-Couto, P., Teixeira-Martins, R., Maia, C., Falcão, M. S., & Laiginhas, R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103344 · Cited by 1
Pitt, M., Olvera‐Barrios, A., Anderson, J., Bolter, L., Chambers, R., Warwick, A., Mann, S. S., Webster, L., Fajtl, J., Barman, S. A., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06379-6 · Cited by 1
Updates in the English Diabetic Eye Screening Programme
Mann, S. S. (2026) · Eye Open · doi:10.1038/s44440-026-00014-y · Cited by 1
Aravindhan, A., Fenwick, E., Chan, A. W. D., Man, R. E. K., Tan, N. C., Wong, W. T., Soo, W. F., Lim, S. W., Wee, S. Y.-M., Sabanayagam, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25405956
Self-citationAravindhan, A., Fenwick, E., Chan, A. W. D., Man, R. E. K., Tan, N. C., Wong, W. T., Soo, W. F., Lim, S. W., Wee, S. Y.-M., Sabanayagam, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25406100
Self-citationTele-Ophthalmology for Diabetic Retinopathy in the UK
Scanlon, P. H. (2023) · Springer eBooks · doi:10.1007/978-3-031-24052-2_23
Self-citationMahmudah, S. H., Sohn, J., Rothwell, J., Mukichi, C., & Lim, K. K. (2026) · Health Policy · doi:10.1016/j.healthpol.2026.105777
Abid, M. (2023) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00046008
Optimising the cost-effectiveness of risk-based screening for diabetic retinopathy
Sampson, C. (2020) · Nottingham ePrints (University of Nottingham)
North, L. (2019) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00046136
Leese, G., STRATTON, I. M., Land, M., Bachmann, M. O., Jones, C. P. A., Scanlon, P. H., Looker, H. C., & Ferguson, B. (2015) · Diabetes Care · doi:10.2337/dci15-0015
Self-citation
Metadata
- Authors
- Leese, G. P., Stratton, I. M., Land, M., Bachmann, M. O., Jones, C., Scanlon, P., Looker, H. C., & Ferguson, B.
- Affiliations
- Ninewells Hospital (GB)
- Gloucestershire Eye Unit, Gloucester, U.K.
- Landmark Health Consulting, York, U.K.
- Norwich Medical School, Norwich, U.K.
- Norfolk and Norwich University Hospital (GB)
- University of Dundee (GB)
- Public Health England (GB)
- Corresponding author
- Leese, Graham P.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-12-18
- Volume
- 38
- Issue
- 3
- Pages
- 488-494
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2020023472
- Cited by
- 50
- References
- 26
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 6 · 2022: 4 · 2021: 1 · 2020: 10 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 8 · 2015: 4
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- green
- orcid.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research Repository (University of Gloucestershire) (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- Research Repository (University of Gloucestershire) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- NHS Diabetic Eye Screening Programme &NIHR Health Technology Assessment (10/66/01)
- Scottish Diabetes Retinal Screening programme
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic retinopathy, retinopathy progression, screening frequency, proliferative diabetic retinopathy, background retinopathy, risk stratification, community screening program, natural history (disease)
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Humans, Male, Mass Screening, Middle Aged, Retina, Retinal Diseases, Retrospective Studies, Time Factors, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.